Search
01/02/2026
Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review
Baniandres, O, Franch, IB, Rull, EV, Moya, AI, Pacheco, MLA, Puchades, AM, Sánchez, JPH, Diaz, FJM, Ruiz, AB, Cantero, AG, Lorenzo, EM, Gutierrez, MG, Fernández-Freire, LR, Payeras, AV, Santos, CM, Bel, PH, Ostiz, SH, Montcusi, JP, Salafranca, MA, Segura, PC, Pallas, IM, Masoliver, AA, Manchón, TM, Mucientes, CD, Apetrei, CLS, Martinez, AB, Serrano, JM, Ortega, CP, del Cura, LR, Barragán, IL, Mur, EC, Olivares, MG, Dobao, PD. Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(2)DOI:10.1111/ijd.70053. PMID:40931458. IF:3.200(Q1/3D).
01/02/2026
Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors
Ara-Martín, M, Moreno, C, Ruiz-Villaverde, R, Serra-Baldrich, E, Hernández-Martín, I, Fortes, MD. Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(2)DOI:10.1111/ijd.70033. PMID:40928003. IF:3.200(Q1/3D).
01/01/2026
Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study
Bejarano, L, Grau-Pérez, M, Paíno-Román, M, Muret, MPG, Morillo, M, Muniesa, C, Torre-Castro, J, Estrach, MT, Díez, EA, Belloso, RML, Peñate, Y, Martínez-Mera, C, Botella-Estrada, R, Eceiza, MJM, Romero, PLO, Blanes, M, Fernández-de-Misa, R, Prieto-Torres, L, Amer, MEP, Iznardo, H, Moreno-Vílchez, C, Servitje, O, García-Doval, I, Cañueto, J. Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2026; 40(1)DOI:10.1111/jdv.20638. PMID:40065681. IF:8.000(Q1/1D).
01/01/2026
Chronic Prurigo: Current Knowledge, Treatment Strategies, Future Perspectives, and Unmet Needs
Figueras-Nart, I, Serra-Baldrich, E, Ständer, S. Chronic Prurigo: Current Knowledge, Treatment Strategies, Future Perspectives, and Unmet Needs. ACTA DERMATO-VENEREOLOGICA. 2026; 106DOI:10.2340/actadv.v106.44285. PMID:41508835. IF:3.700(Q1/2D).
01/01/2026
EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis
Marzo-Ortega, H, Harrison, SR, Fragoulis, GE, Michelena, X, Macía-Villa, C, Aydin, SZ, Balanescu, A, Bertheussen, H, Bundy, C, Chimenti, MS, Gisondi, P, Glintborg, B, Gossec, L, Kalyoncu, U, Lubrano, E, Nagy, G, Wagenaar, W, Puig, L, Queiro, R, Rahman, P, Shumnalieva, R, Soriano, ER, van den Bosch, F, Sande, MMGHV, Sepriano, A, Machado, PM, Siebert, S. EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis. ANNALS OF THE RHEUMATIC DISEASES. 2026; 85(1)DOI:10.1016/j.ard.2025.10.002. PMID:41168056. IF:20.600(Q1/1D).
01/12/2025
ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa
Grau-Pérez, M, Ciudad, C, Molina-Leyva, A, Martorell, A, Vilarrasa, E, Albert, I, Garcias-Ladaria, J, Melgosa, FJ, Rivera, R, Campos, M, Haselgruber, S, Ochando, G, Pascual, JC, García-Ruiz, R, Alfageme, F. ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa. DERMATOLOGY. 2025; 241(5-6)DOI:10.1159/000546647. PMID:40587963. IF:2.700(Q2/4D).